My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sanofi - American Depositary Shares
(NQ:
SNY
)
50.41
+0.39 (+0.78%)
Streaming Delayed Price
Updated: 1:44 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,043,719
Open
50.14
Bid (Size)
50.40 (4)
Ask (Size)
50.42 (1)
Prev. Close
50.02
Today's Range
50.14 - 50.63
52wk Range
44.62 - 60.12
Shares Outstanding
1,250,690,553
Dividend Yield
4.39%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sanofi's Rezurock Approval Stumbles In EU For Chronic Graft-Vs-Host Disease
Today 13:03 EDT
CHMP rejects Sanofi's Rezurock for chronic GVHD in the EU, while approving Wayrilz for ITP, highlighting mixed outcomes for new treatments.
Via
Benzinga
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times
Today 10:03 EDT
The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions.
Via
Benzinga
Performance
YTD
+4.6%
+4.6%
1 Month
+7.6%
+7.6%
3 Month
+3.6%
+3.6%
6 Month
-1.0%
-1.0%
1 Year
-7.4%
-7.4%
More News
Read More
Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program
Today 0:16 EDT
Via
Stocktwits
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
October 14, 2025
Via
Benzinga
Why Immuneering Stock Soared Over 40% After-Hours Today
September 24, 2025
Via
Stocktwits
Is Sanofi Gaining or Losing Market Support?
September 24, 2025
Via
Benzinga
Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out
October 09, 2025
Via
Investor's Business Daily
Sanofi AlphaMedix Study Hits Key Milestones In Phase 2 Study
October 08, 2025
Via
Benzinga
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September
October 05, 2025
Via
The Motley Fool
AI Revolutionizes Pharma: Market Soars Towards $65 Billion by 2033, Promising a New Era of Medicine
October 02, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
October 01, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Novavax Amends Deal With Sanofi, Broadens Partnership
September 30, 2025
Via
Stocktwits
GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley
September 29, 2025
Via
Investor's Business Daily
Immuneering Corporation's Stock Takes a Hit Amidst Funding Round Despite Promising Clinical Data
September 27, 2025
Via
MarketMinute
Amgen Expands US Manufacturing Network Amid New Tariff Policy
September 26, 2025
Via
Benzinga
Topics
Government
World Trade
Sanofi Expands Insulin Savings Program To Cover All US Patients
September 26, 2025
Via
Benzinga
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
September 26, 2025
Via
Benzinga
Topics
Government
World Trade
Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now
September 26, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
FDA Delays Key Sanofi Multiple Sclerosis Drug Decision
September 22, 2025
Via
Benzinga
Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion
September 22, 2025
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Sanofi Reports Early Brivekimig Data, Signals Strong Efficacy And Good Tolerability
September 17, 2025
Via
Benzinga
AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit
September 15, 2025
Via
Benzinga
Topics
Government
Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again
September 08, 2025
Via
Investor's Business Daily
Roblox To Rally Around 34%? Here Are 10 Top Analyst Forecasts For Monday
September 08, 2025
Via
Benzinga
This Veeva Systems Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
September 08, 2025
Via
Benzinga
Frequently Asked Questions
Is Sanofi - American Depositary Shares publicly traded?
Yes, Sanofi - American Depositary Shares is publicly traded.
What exchange does Sanofi - American Depositary Shares trade on?
Sanofi - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Sanofi - American Depositary Shares?
The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market
What is the current price of Sanofi - American Depositary Shares?
The current price of Sanofi - American Depositary Shares is 50.41
When was Sanofi - American Depositary Shares last traded?
The last trade of Sanofi - American Depositary Shares was at 10/17/25 01:44 PM ET
What is the market capitalization of Sanofi - American Depositary Shares?
The market capitalization of Sanofi - American Depositary Shares is 63.05B
How many shares of Sanofi - American Depositary Shares are outstanding?
Sanofi - American Depositary Shares has 63B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.